Shulman, K. I., Herrmann, N., & Walker, S. E. (2013). Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression. CNS drugs, 27(10), 789-797. https://doi.org/10.1007/s40263-013-0097-3
Chicago Style (17th ed.) CitationShulman, Kenneth I., Nathan Herrmann, and Scott E. Walker. "Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression." CNS Drugs 27, no. 10 (2013): 789-797. https://doi.org/10.1007/s40263-013-0097-3.
MLA (9th ed.) CitationShulman, Kenneth I., et al. "Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression." CNS Drugs, vol. 27, no. 10, 2013, pp. 789-797, https://doi.org/10.1007/s40263-013-0097-3.
Warning: These citations may not always be 100% accurate.